Factors influencing serum CA125II levels in healthy postmenopausal women.

Factors influencing serum CA125II levels in healthy postmenopausal women.
复制标题

DOI:
--
复制
发表时间:
2001-05
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
通讯作者:
D. Pauler;U. Menon;M. McIntosh;H. Symecko;S. Skates;I. Jacobs
D. Pauler;U. Menon;M. McIntosh;H. Symecko;S. Skates;I. Jacobs
中科院分区:
其他
文献类型:
--
作者:
D. Pauler;U. Menon;M. McIntosh;H. Symecko;S. Skates;I. Jacobs

文献摘要

相似文献

Our objective was to identify factors that correlate with CA125 concentrations in healthy postmenopausal women and to introduce recommendations for reporting and interpreting individual CA125 assay results. We analyzed repeated serum CA125 levels, as measured by the CA125II assay, in 18,748 postmenopausal women who participated in the ST: Bartholomew's/Royal London Hospital Ovarian Cancer screening trial from 1986 to 1994 and were not diagnosed with ovarian cancer during the 12-year follow-up period. We found that race is a substantial predictor of normal levels of CA125, with average CA125II concentration from African (median, 9.0; 95% range, 4.0-26.0 units/ml) and Asian women (median, 13.0; range, 5.9-33.3 units/ml) lower than that in Caucasian women (median, 14.2; range, 6.0-41.0 units/ml; P 0.05). We concluded that clinically significant differences in individual patient characteristics need to be reflected in the screening algorithms that use CA125II so that designed performance characteristics (sensitivity and specificity) are maintained in practice.